Natural Product: NPC56109

Natural Product IDNPC56109
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Ergocristine
IUPAC Name n.a.
Synonyms Ergocristine
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL446315
PubChem CID 31116
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002679] Ergoline and derivatives
        • [CHEMONTID:0002680] Lysergic acids and derivatives
          • [CHEMONTID:0002030] Ergopeptines
            • [CHEMONTID:0000371] Ergotamines, dihydroergotamines, and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HEFIYUQVAZFDEE-MKTPKCENSA-N
Standard InCHI InChI=1S/C35H39N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,16,18,20,23,27-29,36,44H,8,13-15,17,19H2,1-3H3,(H,37,41)/t23-,27-,28+,29+,34-,35+/m1/s1
SMILES CC(C)[C@@]1(C(=O)N2[C@@H](Cc3ccccc3)C(=O)N3CCC[C@H]3[C@]2(O)O1)N=C([C@@H]1C=C2c3cccc4c3c(C[C@H]2N(C)C1)c[nH]4)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   609.3 Volume:   615.398
?
Van der Waals volume.
Dense:   0.99 LogP:   3.179
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.058
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.231
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   42.0
TPSA:   121.7
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   3.0 Rings:   8.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.301 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.06 Fsp3:   0.457
MCE-18:   161.275
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.667 Fluc inhibitor:   0.018
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.927
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.99
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.942

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.634 MDCK Permeability:   -5.132
Pgp-inhibitor:   1.0 Pgp-substrate:   1.0
PAMPA:   0.003
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.142
20% Bioavailability (F20%):   1.0 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.636
Plasma Protein Binding (PPB):   96.549% Volume Distribution (VD):   0.967
Fu: 1.474%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.962 BCRP inhibitor:   0.211
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.971 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.992 CYP2C19-substrate:   0.015
CYP2C9-inhibitor:   0.708 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.362
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   0.009
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.601
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  12.307 Half-life (T1/2):  2.054

ADMET: Toxicity

hERG Blockers:  0.054 hERG Blockers (10um):  0.078
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  0.991
AMES Toxicity:  0.905 Rat Oral Acute Toxicity:  0.73
Maximum Recommended Daily Dose:  0.869 Skin Sensitization:  1.0
Carcinogencity:  0.949 Eye Corrosion:  0.0
Eye Irritation:  0.017 Respiratory Toxicity:  0.43
Drug-induced Neurotoxicity:  0.752 Ototoxicity:  0.75
Hematotoxicity:  0.49 Drug-induced Nephrotoxicity:  0.348
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.078
A549 Cytotoxicity:  0.043 Hek293 Cytotoxicity:  0.721
BCF:   1.236
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.091
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.453
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.024
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. PMID[17841110]
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. PMID[20778930]
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO24009 Claviceps purpurea Species Clavicipitaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT211 Individual protein Hypoxia-inducible factor 1 alpha Homo sapiens Potency = 10000.0 nM PubChem BioAssay data set
NPT3 Individual protein Thioredoxin glutathione reductase Schistosoma mansoni Potency = 8912.5 nM PubChem BioAssay data set
NPT151 Individual protein 15-hydroxyprostaglandin dehydrogenase [NAD+] Homo sapiens Potency = 25118.9 nM PubChem BioAssay data set
NPT1456 Individual protein P-glycoprotein 1 Mus musculus Ki = 15300.0 nM PMID[12235267]
NPT1455 Individual protein P-glycoprotein 3 Mus musculus Ki = 39400.0 nM PMID[12235267]
NPT10 Individual protein Geminin Homo sapiens Potency n.a. 2310.9 nM PubChem BioAssay data set
NPT105 Individual protein Muscleblind-like protein 1 Homo sapiens Potency n.a. 31622.8 nM PubChem BioAssay data set
NPT55 Individual protein Putative fructose-1,6-bisphosphate aldolase Giardia intestinalis Potency = 3154.8 nM PubChem BioAssay data set
NPT533 Protein-protein interaction Runt-related transcription factor 1/Core-binding factor subunit beta Homo sapiens Potency n.a. 31622.8 nM PubChem BioAssay data set
NPT612 Individual protein Canalicular multispecific organic anion transporter 1 Homo sapiens Activity = 60.0 % PMID[18457386]
NPT48 Individual protein Lysine-specific demethylase 4D-like Homo sapiens Potency = 25118.9 nM PubChem BioAssay data set
NPT94 Individual protein Aldehyde dehydrogenase 1A1 Homo sapiens Potency = 17782.8 nM PubChem BioAssay data set
NPT54 Individual protein Nonstructural protein 1 Influenza A virus Potency = 2511.9 nM PubChem BioAssay data set
NPT61 Individual protein Beta-glucocerebrosidase Homo sapiens Potency n.a. 39810.7 nM PubChem BioAssay data set
NPT46 Individual protein Thyroid hormone receptor beta-1 Homo sapiens Potency = 50118.7 nM PubChem BioAssay data set
NPT93 Individual protein Survival motor neuron protein Homo sapiens Potency = 1122.0 nM PubChem BioAssay data set
NPT51 Individual protein Microtubule-associated protein tau Homo sapiens Potency = 12589.3 nM PubChem BioAssay data set
NPT51 Individual protein Microtubule-associated protein tau Homo sapiens Potency = 25118.9 nM PubChem BioAssay data set
NPT197 Protein-protein interaction Menin/Histone-lysine N-methyltransferase MLL Homo sapiens Potency = 14125.4 nM PubChem BioAssay data set
NPT53 Individual protein 4'-phosphopantetheinyl transferase ffp Bacillus subtilis Potency = 56234.1 nM PubChem BioAssay data set
NPT5 Individual protein Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 Homo sapiens Potency n.a. 8912.5 nM PubChem BioAssay data set
NPT668 Individual protein P-glycoprotein 1 Homo sapiens Ki = 13330.0 nM PMID[11961113]
NPT668 Individual protein P-glycoprotein 1 Homo sapiens Ki = 42800.0 nM PMID[11961113]
NPT49 Individual protein DNA-(apurinic or apyrimidinic site) lyase Homo sapiens Potency n.a. 1122.0 nM PubChem BioAssay data set

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Potency n.a. 2332.3 nM PubChem BioAssay data set
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Potency n.a. 2936.2 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 29092.9 nM PubChem BioAssay data set
NPT2 Others Unspecified n.a. Potency n.a. 20596.2 nM PubChem BioAssay data set

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC56109 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8969 High Similarity NPC191382
0.8454 Intermediate Similarity NPC155444
0.6036 Remote Similarity NPC603739
0.5657 Remote Similarity NPC68354
0.534 Remote Similarity NPC611966
0.5146 Remote Similarity NPC604662

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC56109 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8969 High Similarity NPD7781 Phase 4
0.8365 Intermediate Similarity NPD7780 Approved
0.7358 Intermediate Similarity NPD7952 Approved
0.7358 Intermediate Similarity NPD7953 Pre-clinical
0.6789 Remote Similarity NPD7717 Phase 4
0.6577 Remote Similarity NPD7790 Approved
0.6577 Remote Similarity NPD7791 Phase 4
0.6555 Remote Similarity NPD7951 Phase 4
0.6491 Remote Similarity NPD7716 Approved
0.6293 Remote Similarity NPD7789 Approved
0.629 Remote Similarity NPD7950 Approved
0.6126 Remote Similarity NPD7731 Pre-clinical
0.5965 Remote Similarity NPD7824 Approved
0.5913 Remote Similarity NPD7271 Approved
0.5862 Remote Similarity NPD7730 Approved
0.57 Remote Similarity NPD4079 Phase 4
0.5657 Remote Similarity NPD3506 Phase 4
0.5377 Remote Similarity NPD4076 Approved
0.5333 Remote Similarity NPD3505 Approved
0.5051 Remote Similarity NPD4075 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data